Chemoinformaics analysis of 9,10-secocholesta-5,7,10(19)-triene-3,24,25-triol.
| Molecular Weight | 416.646 | nRot | 6 |
| Heavy Atom Molecular Weight | 372.294 | nRig | 19 |
| Exact Molecular Weight | 416.329 | nRing | 3 |
| Solubility: LogS | -4.197 | nHRing | 0 |
| Solubility: LogP | 4.123 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 76.8349 |
| nHD | 3 | BPOL | 44.1411 |
| QED | 0.52 |
| Synth | 4.585 |
| Natural Product Likeliness | 2.899 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.973 |
| Pgp-sub | 0.011 |
| HIA | 0.016 |
| CACO-2 | -4.762 |
| MDCK | 0.0000126 |
| BBB | 0.528 |
| PPB | 0.947932 |
| VDSS | 1.328 |
| FU | 0.0281495 |
| CYP1A2-inh | 0.061 |
| CYP1A2-sub | 0.341 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.792 |
| CYP2c9-inh | 0.211 |
| CYP2c9-sub | 0.201 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.341 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.623 |
| CL | 3.941 |
| T12 | 0.12 |
| hERG | 0.062 |
| Ames | 0.036 |
| ROA | 0.154 |
| SkinSen | 0.874 |
| Carcinogencity | 0.051 |
| EI | 0.009 |
| Respiratory | 0.892 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.636923 |